Cite Filings / IMVT / 0001764013-25-000103

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Immunovant, Inc. Filed 2025-07-09 Acc 0001764013-25-000103

Documents 1

DEF 14A Proxy Statement , imvt-20250709.htm

Around this filing

2026-07-22 DEF 14A Proxy Statement
2025-07-11 4 Chief Medical Officer sold 1,160 shares at $17.24 ($19,998)
2025-07-11 4 Chief Technology Officer sold 1,519 shares at $17.24 ($26,188)
2025-07-09 ARS Annual Report to Security Holders
2025-07-09 DEFA14A Proxy Materials
2025-07-09 DEF 14A Proxy Statement
2024-06-26 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading imvt-20250709.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…